Oncology
Highly potent oncology injectables in France
In France, for an international pharmaceutical manufacturer: the revamp of an injectables production unit into a highly potent oncology injectables unit to SafeBridge criteria, an €11 million project approved by the FDA and EMA.
- FDA
- EMA

Project fact sheet
- Client
- International pharmaceutical manufacturer
- Location
- France
- Years
- 2005 à 2008
- Engagement
- EPCM
- Facility
- Oncology injectables and solid dosage forms (OEL 5)
- Scale
- 11 M€
Engagement : EPCM
- EEngineeringEngineering
- PProcurementProcurement
- CConstructionConstruction
- MManagementManagement
- VValidationValidation
Process equipment
- Freeze dryer
- Clean-in-place (CIP)
- Laminar airflow
- Water for injection (WFI) and pure steam
- Vaporized hydrogen peroxide (VHP) decontamination
- High-containment isolator
- Process cleanroom HVAC
- Utilities: chilled water, steam, compressed air, nitrogen and effluent treatment

















































